ABBV-706
ABBV-706 is a SEZ6 targeting ADC, which is composed of the Linker-Payload conjugation and the Anti-SEZ6 Antibody (SC17) (HY-P991041). ABBV-706 exhibits high efficacy against small cell lung cancer (SCLC), neuroendocrine tumors (NENs) and central nervous system (CNS) tumors[1].
Product Specifications
UNSPSC
12352211
Target
Antibody-Drug Conjugates (ADCs)
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/abbv-706.html
Purity
99.71
Smiles
[ABBV-706]
References & Citations
[1]Chandana S R, et al. First-in-human study of ABBV-706, a seizure-related homolog protein 6 (SEZ6) –targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors[J]. 2024.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1123651-01 0.02 mg (E-Coli)
Recombinant Haemophilus influenzae Bifunctional protein HldE (hldE)
Sign In for Pricing
View Details MBS1123651-02 0.02 mg (Yeast)
Recombinant Haemophilus influenzae Bifunctional protein HldE (hldE)
Sign In for Pricing
View Details MBS1123651-03 0.1 mg (E-Coli)
Recombinant Haemophilus influenzae Bifunctional protein HldE (hldE)
Sign In for Pricing
View Details MBS1123651-04 0.1 mg (Yeast)
Recombinant Haemophilus influenzae Bifunctional protein HldE (hldE)
Sign In for Pricing
View Details MBS1123651-05 0.02 mg (Baculovirus)
Recombinant Haemophilus influenzae Bifunctional protein HldE (hldE)
Sign In for Pricing
View Details MBS1123651-06 0.02 mg (Mammalian-Cell)
Recombinant Haemophilus influenzae Bifunctional protein HldE (hldE)
Sign In for Pricing
View Details